BG
Boris Georg Roeder
About Boris Georg Roeder
Data last updated:
Boris Georg Roeder is a Director at Ursapharm India Private Limited (since 2006). The company operates in Pharma. Ursapharm India Private Limited reported revenue of ₹6.22 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ursapharm India Private Limited U24232DL2006FTC154392 | Director | 27 Sep 2006 | 2006 | ₹6.22 Cr (FY 2024) | Active |
Board colleagues of Boris Georg Roeder
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rohit Jain | 00247796 | Ursapharm India Private Limited | Managing Director |
| Uwe Hurth | 07900128 | Ursapharm India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Boris Georg Roeder
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Boris Georg Roeder
Boris Georg Roeder currently holds 1 directorship: Ursapharm India Private Limited (Director, since 27 Sep 2006, revenue ₹6.22 Cr (FY 2024)).
Boris Georg Roeder was first appointed on 27 Sep 2006 as Director at Ursapharm India Private Limited.
The current boards of Boris Georg Roeder's companies include Rohit Jain (Ursapharm India Private Limited), Uwe Hurth (Ursapharm India Private Limited).